Wells Bio Co., Ltd. recently obtained export permission for its first independently developed pneumonia molecular diagnostic kit "careGENEâ„¢ Pneumonia detection kit."
Wells Bio Co., Ltd. recently obtained export permission for its first independently developed pneumonia molecular diagnostic kit "careGENEâ„¢ Pneumonia detection kit."
"careGENEâ„¢ Pneumonia detection kit (No. 22-389)" is an in vitro diagnostic device that helps diagnose pneumonia infection by detecting the nucleic acid of pneumonia-causing bacteria